Contact Andrea Orsey, MD, MSCE
860.545.9630

Request An Appointment

Andrea Orsey, MD, MSCE

Associate Chair of Education
Director, Pediatric Hematology/Oncology Fellowship Program
Director, Cancer Supportive Care Program
Pediatric Hematologist/Oncologist


Loading...
Practice Name Connecticut Children's Specialty Group
Education

Education:
BS, McGill University, 1996
MD, University of Connecticut School of Medicine, 2001
MSCE, University of Pennsylvania, 2007
Residency:
Pediatrics, Children’s Hospital of Philadelphia, 2001-2004
Fellowship:
Pediatric Hematology/Oncology, Children’s Hospital of Philadelphia, 2004-2007

Board Certifications
  • Pediatrics
  • Pediatric Hematology/Oncology
  • Faculty Appointment

    Associate Professor of Pediatrics, University of Connecticut School of Medicine

    Clinical Expertise

    Dr. Orsey obtained her medical degree from the University of Connecticut School of Medicine and a MSCE with an emphasis on clinical trials from the Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania. She completed her pediatric residency and pediatric hematology/oncology fellowship at the Children’s Hospital of Philadelphia. Dr. Orsey is board-certified with the American Board of Pediatrics in Pediatrics and Pediatric Hematology-Oncology is the director of the Cancer Supportive Care Program. She is the director of the Pediatric Hematology/Oncology Fellowship Program as well as the Associate Chair for Education. She is a member of the American Society of Hematology, the American Society of Pediatric Hematology and Oncology, American Society for Clinical Oncology, International Society of Pediatric Oncology and Children’s Oncology Group. Dr. Orsey conducts clinical research evaluating physical activity, quality of life, fatigue and sleep in pediatric oncology patients.

    Selected Publications
    • Hyslop S, Dupuis LL, Baggott C, Dix D, Gibson P, Kuczynski S, Johnston DL, Orsey A, Portwine C, Price V, Spiegler B, Tomlinson D, Vanan M, Tomlinson GA, Sung L. Validation of the Proxy Version of Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments. J Pain Symptom Manage.2018 Jul; 56(1):107-112

    • Patel P, Robinson PD, Thackray J, Flank J, Holdsworth MT, Gibson P, Orsey A, Portwine C, Freedman J, Madden JR, Phillips R, Sung L, Dupuis LL. Guideline for the Prevention of Acute Chemotherapy-induced Nausea and Vomiting in Pediatric Cancer Patients: A Focused Update. Pediatr Blood Cancer. 2017 Oct;64(10).

    • Orsey AD, Park CL, Pulaski R, Shankar NL, Popp JM, Wakefield D. Results of a Pilot Yoga Intervention to Improve Pediatric Cancer Patients’ Quality of Life and Physical Activity and Parents’ Well-being. RehabOnc. 2017 Jan;35(1)15-23.

    • Toro-Salazar OH, Gillan E, Ferranti, J, Orsey AD, Rubin K, Upadhyay S, Mazur W, Hor KN. Effect of myocardial dysfunction in cardiac morbidity and all-cause mortality in childhood cancer subjects treated with anthracycline therapy. Cardio-Oncology. 2015 Nov;1(1).

    • Orsey AD*, Wakefield DB, Cloutier MM. Physical activity (PA) and sleep among children and adolescents with cancer. Pediatr Blood Cancer. 2013 Nov;60(11):1908-13.

    Patient Feedback The Patient Rating score is an average of all responses to physician related questions on our nationally-recognized Patient Satisfaction Survey . Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments also are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

    QUESTION BREAKDOWN

    RATINGS DISTRIBUTION AND COMMENTS


    Back to Top
    Searching Animation
    Searching